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DOI: 10.1039/b910960aIn nature, organisms control crystal nucleation and growth using organic interfaces as templates.
Scientists, in the last decades, have tried to learn from nature how to design biomimetic biomaterials
inspired by the hierarchical complex structure of bone and other natural mineralised tissues or to
control the biomineralization process onto biomaterials substrates to promote the osteoconductive
properties of implantable devices. The design of synthetic bone analogues, i.e., with a structure and
properties similar to bone, would certainly constitute a major breakthrough in bone tissue engineering.
Moreover, many strategies have been proposed in the literature to develop bioactive bone-like
materials, for instance using bioactive glasses. Fundamental aspects of biomineralization may be also
important in order to propose new methodologies to improve calcification onto the surface of
biomaterials or to develop bioactive tridimensional templates that could be used in regenerative
medicine. In particular, it has been shown that some chemical groups and proteins, as well as the
tridimensional matrix in which calcification would occur, play a fundamental role on the nucleation
and growth of hydroxyapatite. All these distinct aspects will be reviewed and discussed in this paper.1. Bone: a complex structure
Hard tissues in vertebrates, such as bones, are exquisite examples
of structures arranged from nanometre to macroscopic scale,
produced by natural biomineralization using organic templates
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This journal is ª The Royal Society of Chemistry 2010a hierarchically structured composite material which has been
well studied by the materials engineering community because of
its unique structure and mechanical properties.1 From a mate-
rials science perspective, the nanostructure of bone is intriguing
and even quite difficult to define. Bone structure is, however,
increasingly being understood as a result of better analytical and
high resolution microscopy instrumentation. The fundamental
subunit is mineralized collagen fibril that consists of self-assem-
bled triple helices of collagen molecules. Hydroxyapatite nano-
crystals grow on these assembled fibrils, with their
crystallographic c-axes aligned with the fibril long axes. It is still
not entirely understood whether the hydroxyapatite crystals are
directly nucleated on the collagen fibrils, or if the hydroxyapatiteI: B: Leonor
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mineralization is directed by other charged macromolecules,
which may be associated with the self-assembled collagen
structures. Although collagen has been considered the most
important biopolymer in the regulation of bone structure, it is
clearly not the sole source responsible for the regulation of bone
mineralization since the majority of the body is composed of
collagenous tissues that never mineralize. Thus, the role of the
noncollagenous proteins (NCPs) associated with bone is
considered to be important in either inhibiting or promoting
interactions during crystal nucleation and growth. Some of these
proteins are highly acidic, and include proteins that are enriched
in aspartic or glutamic acid residues, or phosphorylated
serine/threonine.2
Because intrafibrillar mineralization does not occur simply by
trying to crystallize collagen in vitro using supersaturated
solutions of hydroxyapatite (crystals only nucleate heteroge-
neously at the surface of the collagen fibers), it is generally
assumed that the collagen substrate does not act alone in
directing crystal growth, and that the NCPs found in regions ofH: S: Azevedo
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2912 | J. Mater. Chem., 2010, 20, 2911–2921bone growth play an essential role in calcification due to their
ability to bind calcium and their high affinity for collagen. Acidic
polypeptide additives used to modify crystal growth of calcium-
based minerals have demonstrated a crystallization mechanism
that proceeds through a liquid-phase mineral precursor. Various
features of the crystals produced via this mechanism, such as
‘‘extruded’’ mineral fibers and mineralized collagen composites,
have led Olszta and colleagues3–5 to propose a new and very
different view on bone mineralization. They hypothesize that an
amorphous, liquid-phase precursor could play a fundamental
role in the morphogenesis of calcium-based biominerals. They
suggest that the charged polymer acts as a process-directing
agent, by which the conventional solution crystallization is
converted into a precursor process. This polymer-induced liquid-
precursor (PILP) process generates an amorphous liquid-phase
mineral precursor to hydroxyapatite which facilitates intra-
fibrillar mineralization of collagen because the fluidic character
of the amorphous precursor phase enables it to be drawn into the
nanoscopic gaps and grooves of collagen fibrils by capillary
action. Once this highly concentrated phase has infiltrated the
fibers, the precursor then solidifies and crystallizes upon loss of
hydration waters into the more thermodynamically stable phase,
leaving the collagen fibrils embedded with nanoscopic hydroxy-
apatite crystals.
It is clear, however, that template-driven biomineralization,
regulated by a number of extracellular matrix components and
the participation of bone cells, plays an important role in the
formation of bone. Mineralized tissues, such as bone and shells,
can in fact be looked as bioceramic–biopolymer composites
made by cell-mediated processes.6 Their production involves an
exquisite level of control both of the spatial regulation of the
nucleation and growth of mineral and of the development of
micro-architecture during formation of these structures.6 The
key components in such sophisticated mineralized tissues are
macromolecules that cells produce and which are subsequently
incorporated into the biological material.7,8 These macromole-
cules may be involved in a wide variety of functions, such as cell
adhesion, ion transport, matrix construction, crystal inductionJ: F: Mano
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and crystal growth regulation,7,8 such as the acidic (negatively
charged) matrix macromolecules which are intimately involved
in biological crystal growth.7–12 Furthermore, these macromole-
cules are functionalized with acidic groups such as carboxylic
acids, sulfonate and phosphate groups, which allow them to be
an effective metal ion chelator to interact with the inorganic
matrix.7
So, in order to develop biomaterials for replacement and
regeneration of bone defects it would be necessary to create an
implant with a complex structure, in which features of different
length scales can be hierarchically organized, i.e., should mimic
the living tissue from mechanical, chemical, biological and
functional point of view. In order to achieve such an ambitious
goal, it is fundamental to understand the structure and properties
of the original hard tissue to be replaced. For instance, it would
be desirable to prepare synthetic bone analogues that would
match both the chemical and mechanical properties of bone.
Such a material could be both load-bearing (with the appropriate
modulus, strength, and toughness), yet bioresorbable to allow
for the body’s own tissue repair processes to regenerate natural
bone. Moreover it would be necessarily bioactive. The distinct
strategies that have been used to develop bone-like materials,
with their achievements and limitations, will be described and
discussed in the following sections.2. Conventional approaches to develop bioactive
bone-like materials
The bone-bonding ability of a biomaterial is a very important
property for bone tissue regeneration/replacement applications.
Hench et al.13,14 have showed for the first time that some glasses,
which contain SiO2, Na2O, CaO and P2O5 in specific propor-
tions, spontaneously bond to living bone. Since then, many
bioactive glasses such as Bioglass,13,14 bioactive glass ceramics
such as Ceravital,15 A–W glass-ceramic,16,17 or dense calcium
phosphate ceramics such as synthetic hydroxyapatite (HA)18,19
have been used clinically with bone-bonding ability. They have
been developed in the forms of bulks and particulates with dense
and porous structures. For example, Bioglass in the form of
particulates has been extensively used in periodontal bone
repair.20 HA, in bulk and granular forms with dense and porous
structures, is currently used as bone spacers and fillers.21 A–W
glass-ceramic has been applied, not only as bone spacer and filler
in the bulk and granular forms, but also as artificial vertebrae,
intervertebral discs, and iliac crests in dense bulk form.17
Bioactive glasses have also been found to support enzyme
activity,22,23 vascularization,24,25 foster osteoblast adhesion,
growth, differentiation and induce the differentiation of mesen-
chymal cells into osteoblasts,26,27 which are extremely important
aspects regarding tissue engineering applications. Particularly
relevant for the development of bone tissue engineering was the
finding that the dissolution products from bioactive glasses, in
particular the 45S5 Bioglass composition, upregulate the gene
expression that control osteogenesis and the production of
growth factors.28 However, even A–W glass-ceramic, which has
higher mechanical strength than the other bioactive ceramics and
human cortical bone, cannot be used to repair bone defects in
high-load bones, such as femoral and tibial bones, as its fractureThis journal is ª The Royal Society of Chemistry 2010toughness is lower and its elastic modulus is higher than those of
cortical bone.
These bioactive ceramics have the capacity to form
a mechanically strong bond with bone when they are implanted
through a biologically active hydroxycarbonate apatite (HCA)
layer formed on their surface that is chemically and structurally
similar to the mineral phase.13,16,17,29 Such a type of calcium
phosphate (Ca–P) layer is not observed around materials that are
not bioactive, like metals and polymers when implanted in bone
defects, demonstrating that this biologically active bone-like
apatite layer is a prerequisite for the bonding between an artifi-
cial material and living bone.15,30
The analysis of the bioactivity of artificial materials when
implanted in vivo has been reproduced in vitro by immersion
experiments using a simulated physiological solution that mimics
the typical ion concentrations in body fluids.31 The human blood
is composed of proteins, cells and in terms of inorganic ion
species is a highly supersaturated solution with respect to apatite,
however it is too complex to reproduce ex vivo.1 Therefore, to
understand what is the mechanism of apatite formation in
bioactive materials, Kokubo et al.31,32 proposed a protein-free
and acellular simulated body fluid (SBF) with pH 7.40 and ionic
composition (Na+ 142.0, K+ 5.0, Ca2+ 2.5, Mg2+ 1.5, Cl 147.8,
HCO3
 4.2, HPO4
2 1.0, SO4
2 0.5 mM) nearly equal to those of
the human blood plasma.
It is known that each surface-active ceramic has its own
characteristics regarding the formation of the apatite layer. For
example, when Bioglass is soaked in SBF the first reaction of
this type of bioactive glass surface is ion exchange, in which Ca2+
and Na+ in the glass exchange with H3O
+ in the solution,
resulting in a pH increase of the solution as well as in the
formation of a hydrated silica gel layer.14,33 The formation of this
hydrated silica gel layer at the surface of Bioglass, which is
abundant in silanol (Si–OH) groups, provides favourable sites
for the calcium phosphate nucleation.14,34,35 Furthermore, the
water molecules in SBF react with the Si–O–Si bond to form
additional Si–OH groups.36 Then, these functional groups induce
apatite nucleation, and the released Ca2+ and Na+ ions accelerate
apatite nucleation by increasing the ionic activity product (IAP)
of apatite in the fluid. Tanahashi et al.37 have also reported that
Si–OH groups were effective in apatite nucleation. Therefore, the
mineralization induced by bioactive ceramics is due to the
formation of specific surface functional groups such as Si–OH,
which serve as effective sites for heterogeneous nucleation of
Ca–P.38 Additionally, an increase of IAP in the surrounding fluid
could thereby promote the Ca–P nucleation and growth at the
surface of bioactive ceramics.38
So, the extensive use of ceramics in the field of bone tissue
regeneration and replacement, alone or as a component of
a composite, is not only related with the need of developing
materials with adequate mechanical strength, but it is undoubt-
edly due to the bone-bonding ability described in this section,
typically presented by this class of materials.
It must be noted that in a real in vivo situation achieving an
interface that strongly bonds the implant to bone tissue is a great
challenge, in particular because we are dealing with two
mechanically distinct materials. Until now this challenge has not
been fully accomplished, because it is dependent on several
complex aspects such as the adhesion strength of the interface,J. Mater. Chem., 2010, 20, 2911–2921 | 2913
the resistance to wear or even the biological response at the
implant site. Also, in vivo musculoskeletal tissues present
mechanical gradients at interfaces, which reduce stress concen-
trations as loads are redistributed. It is known that the most
common cause of ligament and tendon grafts is rupture at
insertion sites.39 So, a way to improve their in vivo performance
could be the insertion of distinct transition zones to improve load
transfer between tissues in the future substitutes for orthopaedic
applications. Some efforts have been made towards this direction
by proposing scaffolds for osteochondral defects with two or
more layers with distinct compositions and, hence, with distinct
mechanical properties.40,41 However there is still much to do in
order to improve the implant interface in vivo.3. Nanocomposites
The most obvious choice of materials for a synthetic analogue of
bone would be a collagen–hydroxyapatite composite. We can say
that such a composite would mimic the natural bone matrix that,
as described in the introduction, consists primarily of hydroxy-
apatite nanocrystals deposited in between highly ordered
collagen-I fibers. Both components would render the necessary
mechanical strength and, in addition, hydroxyapatite would
confer the necessary bioactivity to collagen. However, from the
research in this area, namely from the attempts to mineralize
collagen in vitro,3 it is clear that the collagen–hydroxyapatite
composites developed so far, typically with microsized mineral
particles, don’t reproduce the collagen/mineral structure of
bone at the nanoscopic level and don’t achieve the high
mineral loading that is attained biologically by intrafibrillar
mineralization.
More recently, work on nanoglasses/nanoceramics and nano-
structured biocomposites have shown that these materials
provide alternatives not yet fully explored for orthopaedic
applications,42 presenting improved mechanical and biocom-
patibility properties and exhibiting, in some extent, a micro- and
nanoarchitecture similar to bone.1,43 When compared with
conventional ceramics or glass micro- or macro-particles, the use
of nano-sized particles may have advantages in bone repair or
regeneration, because it has been shown that the decrease of
grain size allows the up-regulation in cellular adhesion, enhances
osteoblast proliferation and differentiation and the bio-
mineralization process is also enhanced.42 Moreover, the use of
bioactive nanoparticles may have intrinsic sense in the design ofFig. 1 Strategies related to the use of nanoparticles in the production of
bioactive materials: (a) nanocomposites based on the fabrication of nano-
fibers; (b) spatial control of nanoparticles in the production of patterned
bioactive surfaces; (c) bioactive multilayered coatings produced by layer-
by-layer; (d) polymer-based scaffolds; (e) hydrogels or solid bioactive
biomaterials.
2914 | J. Mater. Chem., 2010, 20, 2911–2921materials for biomedical applications. Fig. 1 shows the possi-
bility of using nanoparticles in the fabrication of materials,
organised according to the dimension of the material: fibers (1D);
surfaces (2D); and porous and other 3D systems.
The combination of a polymeric matrix and bioactive nano-
particles may be used to produce nanocomposites composed by
nanofibers (Fig. 1a). For example, electrospinning has been used
for this purpose, in which hydroxyapatite nanoparticles were
utilized.44–46
Nanoparticles can also be deposited onto surfaces. The spatial
control of the regions where the nanoparticles are dispersed may
produce patterned bioactive surfaces (Fig. 1b). Moreover, we can
also control the deposition of nanoparticles on surfaces in which
the coating thickness may be controlled, using, for example
layer-by-layer technology (Fig. 1c). Such methodology has been
used to produce multilayered organic–inorganic composite films
that included bioactive glass nanoparticles.47 The obtained
bioactive coatings tried to mimic the ordered brick-and-mortar
arrangement found in the microstructure of seashell nacre,
known for its superior hardness, strength and toughness.48
Nanoparticles can also be included in 3D composite materials as
one may improve the final mechanical properties as compared
with the use of larger particles. Bioactive nanoparticles may be
included in scaffolds (Fig. 1d); for example, poly(L-lactic acid)-
based scaffolds containing bioactive glass nanoparticles, induced
the precipitation of apatite onto the surface of the pores upon
immersion of SBF.49 Non-porous materials including nano-
particles in the form of gels or hard devices may also be produced
(Fig. 1e). As an example, chitosan–b-glycerophosphate salt
formulation with bioactive glass nanoparticles was conceived
to prepare novel thermo-responsive hydrogels exhibiting a
bioactive character.50 Such systems are liquid at room tempera-
ture and turn to a gel at body temperature, being thus adequate
to be used as an injectable system. The use of nanoparticles in
this context facilitates the introduction of the liquid in situ
through a minimally invasive procedure.
It should be noted that until now it was not possible to develop
composites that match the complexity of bone tissue. In partic-
ular, a critical issue regarding composite implants is the lack of
a well-defined interface between their constituents. Due to this
feature, these materials exhibit serious mechanical property
mismatches with natural bone tissues, which can cause stress
shielding and lead to bone resorption when the material has
a higher Young’s modulus than bone. Very often, revision
surgery will be required to follow up the initial implantation.
A secondmajor limitation of traditional bone implants is the lack
of interaction between these implants and their tissue environ-
ment. These materials typically do not bear any functionalities
that encourage communication with their cellular environment.
These ‘‘static’’ implants are not capable of effectively triggering
the healing cascade upon surgical implantation, therefore
limiting the potential for tissue attachment and in-growth.
Nevertheless, many bone tissue substitutes have been devel-
oped and some are already used in clinical trials or as already
approved therapies. Besides the examples already given we can
also mention some already approved bone substitutes, such as
the Vitoss scaffold FOAM from Orthovita, composed of bovine
type I collagen and b-TCP available since 2004 and the FortrOss
from Pioner Surgical, available since 2008, composed ofThis journal is ª The Royal Society of Chemistry 2010
nanocrystalline hydroxyapatite and a copolymer of porcine
collagen and dextran, both used to treat bone injuries.
4. Designing functionalized surfaces to render
biomaterials self-mineralisable
The knowledge about the biomineralization process in natural
mineralized tissues and the fundamental findings on bone-like
apatite formation on bioactive ceramics, previously described,
have provided a platform for developing a new class of bioactive
materials as bone substitutes. Some of the innovative strategies
to render biomaterials self-mineralisable will be discussed in the
following sections.
Research in the area of biomimetic synthesis has been mainly
based upon the premise of surface functionalization. The
functionalised surfaces are believed to be analogous to
nucleation proteins in biological systems in what concerns to
provide energetically favourable interfaces for heterogeneous
nucleation and growth of inorganic films from supersaturated
solutions.2,51,52
In the last decade several strategies have been employed for the
development and investigation of new functional groups for
apatite nucleation. For the readers, it is important to be always in
mind that the ideal implant should present a surface conductive
to or that will induce osseointegration, regardless of the
implantation site, bone quantity, bone quality, etc.53 Besides the
Si–OH groups referred in section 2, other functional groups have
been shown to induce bone-like apatite formation, namely
Ti–OH, Zr–OH, Nb–OH, Ta–OH, –COOH, and PO4H2.
36 All
these functional groups have isoelectric zero points at pH values
much lower than 7 and, thus, are negatively charged in the living
body,54 inducing apatite formation through formations of an
amorphous calcium compound, e.g., calcium silicate, calcium
titanate, and the subsequent formation of an amorphous calcium
phosphate.36 This calcium phosphate spontaneously transforms
into apatite, the stable phase in body environment.55
Understanding the surface chemistry and knowing the main
mechanisms responsible for induction of apatite formation
provided very important tools to design new bioactive materials.
Furthermore, bioactivity can be induced on surfaces that are not
bioactive by themselves, either by the incorporation of functional
groups or by forming thin ceramic phases that have the potential
to form functional groups upon exposure to a body environ-
ment.32,36,56 The key point lies in the design of an organized
functionalized surface to control the mechanisms of heteroge-
neous nucleation. Several examples of these promising bioactive
materials canbe found in literature such as toughbioactivemetals,
soft bioactive inorganic–organic hybrids and bioactive inorganic–
organic three-dimensional composites with a bone-like
structure.36,57,58 For example, Kim et al.59 demonstrated that
heterogeneous nucleation and growth of a bone-like apatite layer
can be induced by hydroxylation of metal oxide surfaces placed in
SBF for different periods of time: the formed Ti–OH groups
induced the apatite formation on it, through formation of an
amorphous calcium titanate and amorphous Ca–P.
In the case of organic surfaces there is an advantage that is the
capacity to tailor their surface to achieve different properties
such as making their surfaces more hydrophilic and capable of
carrying functional groups. In addition, these materials haveThis journal is ª The Royal Society of Chemistry 2010much higher degree of structural flexibility and may have strong
surface-specific binding forces, such as the ability of the func-
tional groups to chelate metal ions.60 Therefore, the new strate-
gies aim to tailor material’s surface not only to render the
materials biologically active, but also to preserve the bulk
properties of the underlying substrate. One true analogue of
biomineralization would be a polymer matrix which can be
placed into a metastable solution and induce precipitation to
occur within the polymer but not in the solution.60
Tanahashi and Matsuda61 have shown that the incorporation
of bihydrogenophosphate (–PO4H2) and carboxyl (–COOH)
groups on self-assembled monolayers (SAMs) are effective for
apatite nucleation but not the amide (–CONH2), hydroxyl
(–OH), amine (–NH2) and methyl (–CH3) groups. Similar work
was developed by Leonor and co-workers62,63 where the incor-
poration of acid groups onto the polymer surfaces, namely
sulfonic (–SO3H) groups, could also serve as effective functional
groups for apatite nucleation (Fig. 2).
Murphy and Mooney64 reported that the process of mineral
growth on biodegradable polymers can be augmented and
controlled by variation in the functional groups present at the
mineral nucleation site or the ionic characteristics of mineral
growth environment. Polymer surface functionalization was
achieved through hydrolysis of poly(lactide-co-glycolide)
(PLGA), which results in an increase in the amount of surface
carboxyl and hydroxyl groups due to scission of polyester chains.
The presence of these groups regulates the calcium binding to the
polymer surface and the heterogeneous mineral growth. Similar
results were obtained by Oyane et al.,65 where bone-like apatite
was formed at the surface of poly(3-caprolactone) (PCL) porous
scaffolds in SBF, previously treated with aqueous NaOH, which
introduced carboxyl groups, and then dipped alternately in
calcium and phosphate ion solutions to induce apatite nucle-
ation. However, this treatment required a long time period to
induce apatite nucleation in SBF and the need to be combined
with calcium ions. Therefore, the same authors demonstrated66
that when PCL is previously treated with O2 plasma, and then
dipped alternately in alcoholic solutions containing calcium ions
and phosphate ions, a bone-like apatite layer was formed at the
surfaces of PCL plates and PCL 3D meshes in SBF within 24 h.
An apatite–polymer fiber composite would be a good candi-
date for a bioactive material with analogous mechanical prop-
erties to those of living bone.67 So, it was proposed that such
a type of composite could be synthesized, if the organic fibers
would be arranged in a 3D structure similar to that of collagen
fibers in living bone, and if they would be modified to contain
effective functional groups for apatite nucleation onto their
surface.67 Oyane et al.68,69 successfully produced bioactive films
textured on the 3D-templates of polymers by functionalization,
coupling and hydrolysis of iso-cyanatopropyltriethoxysilane or
sol–gel coupling of calcium silicate on ethylene-vinyl alcohol
(EVOH) polymer. Balas et al.70,71 demonstrated that by treating
organic polymers, namely polyethylene terephthalate (PET),
EVOH and Nylon 6, with a silane-coupling agent and a titania
solution, they were able to induce the formation of bone-like
apatite in SBF.
In the case of polysaccharides, such as carboxymethylated
chitin67 and gellan gum gels,67 it is possible to induce apatite
formation by subjecting them to a very simple alkaline treatment.J. Mater. Chem., 2010, 20, 2911–2921 | 2915
Fig. 2 The relationship between the changes in the surface structure and the potential of the incorporation of –SO3H groups into HMWPE in the
apatite formation process on its surface in SBF: zeta potential (i) and SEM photographs (ii) of the sulfonation and Ca(OH)2 treated HMWPE as
a function of soaking time in SBF. The mechanism of apatite formation on bioactive polyethylene in SBF is due to electrostatic interaction of the
polymer surface and ions in the fluid, which progresses in the following way (iii): formation of –SO3H groups with a negative charge by the Ca
2+ ions
release from the HMWPE sample; formation of an amorphous calcium sulfate with a positive charge by combination of negatively charged –SO3H with
the positively charged Ca2+ ions in the SBF; formation of an amorphous calcium phosphate by combination of the positively charged calcium sulfate
with the negatively charged phosphate ions in the SBF; and formation of the apatite with a negative charge by transformation of the calcium phosphate
into crystalline apatite. Data adapted from the results of ref. 63.Kawashita et al. found that by soaking these gels first in satu-
rated calcium hydroxide (Ca(OH)2) solution and then in SBF,
they become bioactive. This was attributed to the catalytic effect
of the carboxyl groups present on both materials on apatite
nucleation and the acceleration of this process due to the release
of Ca2+ ions. However, in the case of curdlan gels,67 which
present hydroxyl groups, an apatite deposit was not formed even
after the Ca(OH)2 treatment. Such results provide a fundamental
condition for obtaining an apatite–polymer fiber composite with
analogous structure to living bone by using a biomimetic
method.67 Similar research works have been reported by other
authors,72,73 where carboxymethylated chitin and chitosan were
able to induce apatite formation.
Also, Kokubo et al.74 showed that carboxymethylation of
chitin non-woven fabric treated with a saturated Ca(OH)2
aqueous solution induced the formation of an apatite layer
within 3 days in SBF. This kind of composite can be useful as
a flexible bioactive bone-repairing material.
Starch-based polymers such as corn starch with ethylene-vinyl
alcohol (SEVA-C), an organic and quite hydrophilic material,
may be a suitable material for inducing apatite nucleation, as in2916 | J. Mater. Chem., 2010, 20, 2911–2921fact biological mineralization is thought to be induced by anionic
functional groups. SEVA-C, can associate a degradable behav-
iour with an interesting mechanical performance.75,76 However,
in terms of bone bonding, this polymer cannot induce by itself
the formation of an apatite layer without a previous bioactive
coating or the use of bioactive fillers as it has been reported
previously.77,78 The presence of reactive –OH groups on starch
and vinyl alcohol justifies the efforts in trying to incorporate
other polar groups such as –COOH groups in order to obtain
bioactive polymers. For that purpose, a new route was developed
for the surface functionalization of biodegradable polymers,79 in
which two different types of alkaline solutions, calcium
hydroxide solution (Ca(OH)2) and sodium hydroxide solution
(NaOH), were used. This method is based on a wet chemistry
modification, resulting in etching and/or hydrolysis in order to
increase the amount of polar groups such as hydroxyl (–OH) and
carboxylic (–COOH) groups on the surface of the polymer.
Very similar results were also obtained in our research group,
with starch based blends after surface oxidation.80 As mentioned
above, starch itself contains many –OH groups (non-ionic). In
order to alternate non-ionic starch hydroxyl groups withThis journal is ª The Royal Society of Chemistry 2010
Fig. 3 SEM images of unmodified (1) and PNIPAAM grafted (2) films
with 10% of BG after immersing in SBF during 2 weeks at 25 C (A) and
37 C (B). The inset picture corresponds to the EDS spectrum of the CaP
coating formed at 37 C. A scheme is also shown representing the
different conformational states of the PNIPAAm chains at bothnegatively charged carboxyl groups, a surface oxidation by
potassium permanganate (KMnO4)/(NHO3) nitric acid system
was performed.80 The formation of an apatite layer was observed
in different blends of starch and synthetic polymers. The
KMnO4/NHO3 oxidizing system has been shown to be a very
straight-forward applicable method for introducing polar groups
on starch based biomaterials.
These results suggest that these rather simple treatments are
efficient methods for surface functionalization and subsequent
mineral nucleation and growth on biodegradable polymers to be
used for bone related applications. On the other hand, it is
important to comment that even some materials that contain
carboxyl groups on their structure before any treatment do not
form apatite on their surfaces after immersion in SBF. This
indicates that the catalytic effect of these functional groups is not
strong enough to induce apatite nucleation by itself.67
All the studies shown here share a common finding in which
a surface with an organized arrangement of functional groups
can act as a template for the biomimetic growth of apatite. On
the basis of this research several kinds of bone-bonding material
with different mechanical properties can be developed in the
future.
temperatures. Data adapted from the results of ref. 83.
Fig. 4 SEM images of unmodified (1) and chitosan grafted (2) films with
30% of BG after immersing in SBF during 3 weeks at pH 5.4 (A) and
pH 7.4 (B). The inset images show the water contact angle measurements
for the referred materials. Data adapted from the results of ref. 84.5. Smart mineralizing surfaces
Many examples exist in the area of biology/materials science
interface where polymers that react reversibly to external stimuli
are used in systems designed to respond to specific environmental
changes, with biological applications that include drug delivery,
cell culturing or tissue engineering/regenerative medicine.81,82
The use of these so-called stimuli-responsive polymers has also
been proposed to introduce a smart character in the control of
biomineralization.83,84 In these works the surface of bioactive
substrates, composed by poly(L-lactic acid) reinforced with
Bioglass, was modified by coupling either poly(N-iso-
propylacrylamide) (PNIPAAm),83 a thermo-responsive polymer,
and chitosan, a pH-responsive polymer,84 using plasma
activation. It was shown that surface biomimetic mineralization
may be triggered by these two types of stimuli: a temperature
change83 or a pH change.84
PNIPAAm is the most studied synthetic thermo-responsive
polymer and exhibits a lower critical solution temperature
(LCST) at about 32 C in aqueous solution, changing sharply
from a hydrophilic to a hydrophobic state upon heating.85 It is
believed that this transition involves the breakage of intermo-
lecular hydrogen bonds between the water molecules and the
amide groups in the polymeric chains, which are replaced, above
the LCST, by intramolecular hydrogen bonds amongst the
dehydrated amine groups. The thermo-responsive nature of the
modified composites was easily confirmed by contact angle
measurements. The water contact angle for the PNIPAAm
modified PLLA + 10% BG film was 51.9 2.4, at 25 C whereas
at 37 C it changed to 58.8  2.4, being consistent with the
increase in the hydrophobicity of the surface above the LCST.83
It was found that these conformational changes occurring at the
surface influence the apatite formation of the bioactive
composites below and above the LCST after being immersed
during 2 weeks in SBF. In fact, for the PNIPAAm modified
composite film with 10% BG no apatite formation could beThis journal is ª The Royal Society of Chemistry 2010observed at 25 C (Fig. 3). However, at 37 C the treated film
could form dense precipitates with the typical cauliflower
morphology, containing needle-like nanometric structures,
characteristic of biomimetic-formed apatite (Fig. 3).
Chitosan is a pH responsive polymer that contains both
hydrophobic (–CH3) and hydrogen bonding favouring groups
(–OH, –NH2 and –C]O). In an acidic medium this polymer
becomes positively charged due to the protonation of the free
amine groups (the pKa is 6)86 and polymer–polymer interac-
tions via hydrophobic effect and/or hydrogen bonding junctions
can be hindered due to electrostatic repulsion.87 The pH-res-
ponsive behaviour of the composites modified with this smart
polymer was analysed by contact angle measurements.84 The
unmodified PLLA/BG films revealed a quite hydrophobic char-
acter, presenting a contact angle of 82, independently of the pH.J. Mater. Chem., 2010, 20, 2911–2921 | 2917
After modification, the contact angle changed from 88.9  4.05
at pH 7.4 to 67.6  2.3 at pH 5.4 (Fig. 4). The apatite formation
on the surface upon immersion of the modified films in SBF was
investigated at pH 5.4 and pH 7.4 by SEM.84 It was found that
such modification, together with the effect of pH, could block the
formation of apatite onto the biodegradable substrate when the
pH changed to 5.4 (Fig. 4). On the other hand, a dense apatite
layer was formed at pH 7.4 (Fig. 4). For the unmodified
substrates an apatite layer was formed at both pHs (Fig. 4).
Energy dispersive spectroscopy (EDS), thin-film X-ray
diffraction (TF-XRD) and Fourier transform infrared spec-
troscopy (FTIR) analysis of the coatings formed at 37 C
confirmed the formation of a carbonated apatite mineral similar
to the major mineral component of vertebrate bone tissue.83,84
Although in the above mentioned works temperature and pH
were chosen, this concept of smart apatite formation can obvi-
ously be extended for other source of responsiveness and for
other kind of mineral deposition.
Moreover, by patterning the modification of the surface, it was
possible to combine stimuli (temperature in this case) and spatial
control of biomimetic apatite formation.83 This was achieved by
just exposing some regions of the substrate surface to the plasma
treatment, allowing the insertion of PNIPAAm in specifically
desired areas. Again, no apatite formation was observed for these
modified films at 25 C after 2 weeks immersion in SBF.83
However, apatite aggregates were formed at 37 C, with
a circular shape and randomly distributed over the composite
surface, being consistent with the PNIPAAm patterning gener-
ated during the plasma activation step.83 Other apatite patterns
could be produced (e.g. rows, squares, grids) just by changing the
mask model or using other lithographic methodologies. It is
known that apatite-coated surfaces enable the attachment,
growth and expression of osteogenic genes in osteoblasts-like
cells.88,89 Thus, these apatite patterned surfaces could be used in
fundamental studies on differentiation, adhesion, proliferation
and cell–cell signaling of bone-related cells. These surfaces could
also be used in fundamental co-culture studies involving bone
cells and other kind of cells such as endothelial cells, which could
be useful in bone tissue engineering applications.6. Template-driven mineralization
Crystal growth habit can be modified when the relative order of
surface energies can be changed or when crystal growth along
certain crystallographic directions is selectively hindered by
a crystal growth modifier. In the presence of crystal growth
modifiers, the preferential/selective adsorption of crystal modi-
fiers to a specific crystallographic face becomes stronger than
that of others due to the anisotropy in adsorption stability
decreasing the surface energy of the adsorbed face and inhibiting
the crystal growth perpendicular to this face, thus altering the
final shape of the crystal. In addition, the crystal shape can be
altered if the growth process occurs in a confined environment.90
The topography of the substrate onto which the crystals are
growing may also influence its morphology; this was suggested,
for example, in an apatite precipitation study onto flat or
textured poly(L-lactic acid) surfaces, in a 3D environment.91
The morphological control exerted in biomineralization may
be separated into a three-component system:5 (1) an insoluble2918 | J. Mater. Chem., 2010, 20, 2911–2921organic matrix, that can play a role in the compartmentalization
of the growing mineral and/or templating the nucleation for
controlled crystallographic orientation and/or phase; (2) soluble
acidic proteins that are frequently occluded within the crystal
and are thought to play a role in the control of crystal shape; (3)
vesicular compartments that provide spatial and temporal
control of ion and additive transport to the mineralization front.
Although strategies mimicking nature have partially succeeded in
synthesizing bio-inorganic composite materials, our limited
understanding of fundamental mechanisms has so far kept the
level of hierarchical complexity found in biological systems out
of materials engineer’s capabilities. Different approaches have
been used to control the morphology, microstructure and
complexity of inorganic materials with two and three dimen-
sionalities, including mineralization on artificial interfaces
(self-assembled monolayers), natural and synthetic matrices/
templates for controlled crystal growth, and emerging crystalli-
zation on patterned surfaces for the creation of patterned crys-
tals. These approaches have been, however, extensively studied
for calcium carbonate systems.90,92
Inorganic materials can be artificially structured at different
length-scales using biomineralization and templating
approaches. Crystal growth mimicking biomineralization has
been studied using various kinds of organic molecules and
molecular assembly.
As a first step towards the design and fabrication of biomi-
metic bonelike composite materials, Song and co-workers93,94
have developed a template-driven nucleation and mineral growth
process for the high-affinity integration of hydroxyapatite with
a poly(2-hydroxyethyl methacrylate) (pHEMA) hydrogel. The
described mineralization method takes advantage of the different
solubilities of hydroxyapatite in acidic and basic media and the
chemically labile nature of the ester groups of pHEMA in basic
media. There are several notable features of this procedure. First,
increasing pH and temperature during the process promotes the
hydrolysis of the ethyl ester side chains of pHEMA and leads to
the in situ generation of an acidic surface and a partially acidic
interior that has high affinity for calcium ions, promoting the
nucleation and growth of calcium phosphate on the surface,
along with extensive calcification of the hydrogel interior.
Molecular self-assembly exhibits a number of useful proper-
ties, including the possibility of creating synthetic systems with
high order parameters and can offer the potential for epitaxial
events in synthetic systems that emulate protein-mediated
mineralization.
A designed hierarchical structure was made by the self-
assembly of nanofibrils of mineralized collagen resembling an
extracellular matrix.95 The collagen fibrils were formed by the
self-assembly of collagen triple helices. Hydroxyapatite crystals
grew on the surface of these fibrils in such a way that their c axes
were oriented along the longitudinal axes of the fibrils. The
mineralized collagen fibrils aligned parallel to each other to form
mineralized collagen fibers.
Antonietti et al.96 described a biomimetic approach for the
precipitation of unusual morphological forms of calcium phos-
phate minerals. Double-hydrophilic block copolymers consisting
of a long poly(ethylene oxide) block and a short poly(methacrylic
acid) block, modified by partial alkylation with dodecylamine
(PEO-b-PMAA-C12) were employed as templates for theThis journal is ª The Royal Society of Chemistry 2010
controlled precipitation of calcium phosphate from aqueous
solution at different pH values. They showed that supramolec-
ular preorganization of these water-soluble double hydrophilic
block copolymer can be achieved by hydrophobic modification
within the poly(methacrylic acid) domain. This strategy increases
the density of functional groups within the aggregate and hence
the localized level of supersaturation attainable by metal-ion
sequestration. The polymer micelles act as interactive templates
where the organic/inorganic superstructure can range between
nested clusters of fine nanofibers to compact mesostructures in
which nanoscaled calcium phosphate entities are interspersed
with ordered polymer domains.
Hartgerink et al. have designed a peptide molecule, designated
a peptide amphiphile, that self-assembles into cylindrical nano-
fibers (7 nm in diameter) upon screening of charged groups due
to changes in pH, or addition of multivalent ions. This peptide
amphiphile consists of a long alkyl tail, which conveys hydro-
phobic character to the molecule, and a peptide segment, which is
its hydrophilic block and includes a phosphorylated serine
residue. Once self-assembled, these negatively charged phos-
phorylated serine residues are displayed near the fiber exterior,
which are able to interact strongly with calcium ions and help
direct mineralization of hydroxyapatite. They observed that the
growth of hydroxyapatite crystals was crystallographically
aligned with the fibers’ long axes. This alignment is the same as
that observed between collagen fibrils and hydroxyapatite
crystals in bone.
However, mimicking the natural ‘‘templating’’ of bone
mineralization may require more than just providing a physical
template for calcium phosphate nucleation. It is expected that
both spatial and temporal elements are necessary to achieve
biomimetic mineralization in synthetic materials.
In a recently published paper, Spoerke et al.98 describe an
artificial, in vitro biomineralization process that utilizes a nano-
fiber gel as a 3D substrate for biomimetic hydroxyapatite
mineralization. The system employs the natural enzyme alkaline
phosphatase (ALP) and a phosphorylated, anionic nanofiber gel
matrix to template, in 3D, hydroxyapatite nanocrystals. The
nanofiber surfaces are strongly enriched with negatively chargedFig. 5 Schematic illustration of peptide amphiphile (PA) self-assembly
into a cylindrical nanofiber upon addition of calcium ions (a). A visual-
ization of a HA crystal nucleating off calcium ions spaced 5.46A apart on
the PA nanofiber. The HA crystal is shown with the c-axis parallel to the
long axis of the PA nanofiber (b). Erik D. Spoerke, Shawn G. Anthony
and Samuel I. Stupp, Enzyme Directed Templating of Artificial Bone
Mineral, Adv. Mater., 2009, 21, 425–430. Copyright Wily-VCH Verlag
GmbH & Co. KGaA. Reproduced with permission.
This journal is ª The Royal Society of Chemistry 2010and phosphorylated aminoacid residues, which are expected to
be densely decorated with calcium ions bound during gelation
(Fig. 5a). These ‘‘premineralized’’ surfaces can act as extremely
favorable sites for heterogeneous nucleation of apatite crystals.
The calcium aggregates and early calcium phosphate
seed complexes being exposed to other reactive ions in the
surrounding aqueous environment continue to grow and
crystallize, eventually forming relatively isolated aggregates of
crystals.
Secreted by osteoblasts, ALP liberates phosphates necessary
for hydroxyapatite mineralization from organic phosphates such
as b-glycerolphosphate. Enzymatic release of phosphate ions by
ALP regulates the availability of the mineral precursor and thus
the rate of nanocrystal nucleation. This regulation prevents
uncontrolled mineral precipitation, biasing the system toward
selective, heterogeneous nucleation on the phosphorylated
peptide nanofiber templates. The gradual nature of this enzy-
matic process provides critical regulation of free phosphate
concentration, preventing rapid, uncontrolled nonspecific
mineralization in the incubating medium. Simple introduction of
free phosphates to the mineralizing environment produced rela-
tively uncontrolled calcium phosphate formation. In contrast,
when b-glycerophosphate was used instead of free phosphates,
the phosphate needed for reaction had to be harvested by the
ALP in solution. The enzyme-mediated release of these phos-
phates was sufficiently slow and the solution never became
sufficiently supersaturated with respect to phosphates to allow
spontaneous nucleation of calcium phosphates in solution.
Rather, as phosphates were cleaved from their organic counter-
parts, they were consumed in the mineralization processes
localized on the calcium-laden nanofibers.
The chemistry of these self-assembled synthetic nanofibers
simultaneously provides strong hydroxyapatite nucleation sites,
enriched with local calcium concentrations. What makes this
system distinct from other templating designs was the use of ALP
to moderate phosphate introduction to the system. Utilizing
ALP to regulate the slow introduction of enzymatically-liberated
phosphates to the system was fundamental to provide sufficient
phosphates for mineralization in a time frame that was appro-
priate for specific, nucleation and templated growth of
hydroxyapatite on the nanofibers (Fig. 5b).
Inspired by nature, researchers have made enormous progress
over the last few decades in mimicking some of the key structural
and biochemical functions of bone. However, because the
natural environment of bone tissue is extremely complex to
recreate, none of the current materials imitate the highly orga-
nized structure of mineralized tissues. So far, efforts to produce
biomimetic minerals on organic matrices have focused mostly on
design of the structural template, using collagen, peptides, and
polymers. Understanding the biological processes involved in
bone mineralization is and will be of great importance to design
materials for bone regeneration. Specifically, a quantitative
understanding of the local concentration, distribution, and
interaction of key molecules within normal, diseased, and
regenerating bone, as they change with time, is important to be
able to adequately create bone-like materials. For example, the
calcium and phosphate concentrations to promote apatite
mineralization in bone are controlled by cellular activities, which
are difficult to recreate. In the authors’ opinion, the most obviousJ. Mater. Chem., 2010, 20, 2911–2921 | 2919
materials to mimic bone mineralization will be biomaterials that
can instruct cells to produce the complex integration of mineral
and organic phases that is achieved in human bone and be able to
trigger its regeneration in vivo.
7. Conclusions
Biomineralization processes result in organic/inorganic hybrid
materials with complex shape, hierarchical organization and
superior materials properties. Chemistry, which is inspired by
these processes, aims to mimic biomineralization principles and
to transfer them to the general control of crystallization
processes. However, the principal limitation of the current bio-
inspired bottom-up mineralization approaches is that they can
only yield self-assembled structures up to the micrometre level,
unless an external template is provided. Higher structural levels
that can be found in biominerals are controlled by cell action,
which so far does not have a close synthetic mimic. Therefore,
only structured templates like patterned monolayers, biomineral
replicas, or the original structural biomineral matrix can be
applied to achieve a structuration up to the macroscopic scale.
Nevertheless, despite these limitations, the study of bio-inspired
mineralization and self-assembly processes can help to under-
stand parts of the bone mineralization and explore ways in which
biomineralization principles can be used for the synthesis of
advanced biomaterials. Mimicking the structure of natural bone,
even with very simplified synthetic systems, has already led to
remarkable results concerning the generation of complex mineral
morphologies and control over crystallization events. However,
most of the crystallization mechanisms are still unknown due to
the complexity of the system, which involves time-dependent
structures with sizes spanning the entire colloidal level. In this
way it is certain that there is still much to be learned from the way
nature assembles its many biologically important structures.
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